Phospho-regulation of KIBRA by CDK1 and CDC14 phosphatase controls cell-cycle progression

Biochemical Journal

Volumn 447, Issue 1, 2012, Pages 93-102

  Ji, Ming ^a   Yang, Shuping ^a   Chen, Yuanhong ^a   Xiao, Ling ^a   Zhang, Lin ^a   Dong, Jixin ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cell division cycle 14A B (CDC14A B); Cyclin dependent kinase 1 (CDK1); Hippo pathway; Kidney and brain expressed protein (KIBRA); Mitosis; Phosphorylation

Indexed keywords

AURORA A KINASE; CELL PROTEIN; CYCLIN B; CYCLIN DEPENDENT KINASE 1; KIDNEY AND BRAIN EXPRESSED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PACLITAXEL; PHOSPHOPROTEIN PHOSPHATASE CDC14; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE PROGRESSION; CELL DIVISION; CELL STRESS; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; MICROTUBULE; MITOSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SPINDLE CELL;

AMINO ACID SEQUENCE; BINDING SITES; CDC2 PROTEIN KINASE; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CYCLIN B; DUAL-SPECIFICITY PHOSPHATASES; HEK293 CELLS; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MOLECULAR SEQUENCE DATA; PACLITAXEL; PHOSPHOPROTEINS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PURINES; RECOMBINANT FUSION PROTEINS;

MAMMALIA;

EID: 84866424936     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120751     Document Type: Article

References (62)

1. Kremerskothen, J., Plaas, C., Buther, K., Finger, I., Veltel, S., Matanis, T., Liedtke, T. and Barnekow, A. (2003) Characterization of KIBRA, a novel WW domain-containing protein. Biochem. Biophys. Res. Commun. 300, 862-867
2. Papassotiropoulos, A., Stephan, D. A., Huentelman, M. J., Hoerndli, F. J., Craig, D. W., Pearson, J. V., Huynh, K. D., Brunner, F., Corneveaux, J., Osborne, D. et al. (2006) Common kibra alleles are associated with human memory performance. Science 314, 475-478
3. Almeida, O. P., Schwab, S. G., Lautenschlager, N. T., Morar, B., Greenop, K. R., Flicker, L. and Wildenauer, D. (2008) KIBRA genetic polymorphism influences episodic memory in later life, but does not increase the risk of mild cognitive impairment. J. Cell. Mol. Med. 12, 1672-1676
4. Bates, T. C., Price, J. F., Harris, S. E., Marioni, R. E., Fowkes, F. G., Stewart, M. C., Murray, G. D., Whalley, L. J., Starr, J. M. and Deary, I. J. (2009) Association of KIBRA and memory. Neurosci. Lett. 458, 140-143
5. Schaper, K., Kolsch, H., Popp, J., Wagner, M. and Jessen, F. (2008) KIBRA gene variants are associated with episodic memory in healthy elderly. Neurobiol. Aging 29, 1123-1125
6. Schneider, A., Huentelman, M. J., Kremerskothen, J., Duning, K., Spoelgen, R. and Nikolich, K. (2010) KIBRA: a new gateway to learning and memory? Front. Aging Neurosci. 2, 4
7. Makuch, L., Volk, L., Anggono, V., Johnson, R. C., Yu, Y., Duning, K., Kremerskothen, J., Xia, J., Takamiya, K. and Huganir, R. L. (2011) Regulation of AMPA receptor function by the human memory-associated gene KIBRA. Neuron 71, 1022-1029
8. Duning, K., Schurek, E. M., Schluter, M., Bayer, M., Reinhardt, H. C., Schwab, A., Schaefer, L., Benzing, T., Schermer, B., Saleem, M. A. et al. (2008) KIBRA modulates directional migration of podocytes. J. Am. Soc. Nephrol. 19, 1891-1903
9. Rosse, C., Formstecher, E., Boeckeler, K., Zhao, Y., Kremerskothen, J., White, M. D., Camonis, J. H. and Parker, P. J. (2009) An aPKC-exocyst complex controls paxillin phosphorylation and migration through localised JNK1 activation. PLoS Biol. 7, e1000235
10. Yoshihama, Y., Sasaki, K., Horikoshi, Y., Suzuki, A., Ohtsuka, T., Hakuno, F., Takahashi, S., Ohno, S. and Chida, K. (2011) KIBRA suppresses apical exocytosis through inhibition of aPKC kinase activity in epithelial cells. Curr. Biol. 21, 705-711
11. Hilton, H. N., Stanford, P. M., Harris, J., Oakes, S. R., Kaplan, W., Daly, R. J. and Ormandy, C. J. (2008) KIBRA interacts with discoidin domain receptor 1 to modulate collagen-induced signalling. Biochim. Biophys. Acta 1783, 383-393
12. Baumgartner, R., Poernbacher, I., Buser, N., Hafen, E. and Stocker, H. (2010) The WW domain protein kibra acts upstream of hippo in Drosophila . Dev. Cell 18, 309-316
13. Genevet, A., Wehr, M. C., Brain, R., Thompson, B. J. and Tapon, N. (2010) Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev. Cell 18, 300-308
14. Yu, J., Zheng, Y., Dong, J., Klusza, S., Deng, W. M. and Pan, D. (2010) Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev. Cell 18, 288-299
15. Halder, G. and Johnson, R. L. (2011) Hippo signaling: growth control and beyond. Development 138, 9-22
16. Pan, D. (2010) The Hippo signaling pathway in development and cancer. Dev. Cell 19, 491-505
17. Zhao, B., Li, L., Lei, Q. and Guan, K. L. (2010) The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 24, 862-874
18. Hill, V. K., Dunwell, T. L., Catchpoole, D., Krex, D., Brini, A. T., Griffiths, M., Craddock, C., Maher, E. R. and Latif, F. (2011) Frequent epigenetic inactivation of KIBRA, an upstream member of the Salvador/Warts/Hippo (SWH) tumor suppressor network, is associated with specific genetic event in B-cell acute lymphocytic leukemia. Epigenetics 6, 326-332
19. Shinawi, T., Hill, V., Dagklis, A., Baliakas, P., Stamatopoulos, K., Agathanggelou, A., Stankovic, T., Maher, E. R., Ghia, P. and Latif, F. (2012) KIBRA gene methylation is associated with unfavorable biological prognostic parameters in chronic lymphocytic leukemia. Epigenetics 7, 211-215
20. Xiao, L., Chen, Y., Ji, M. and Dong, J. (2011) KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases. J. Biol. Chem. 286, 7788-7796
21. Chiba, S., Ikeda, M., Katsunuma, K., Ohashi, K. and Mizuno, K. (2009) MST2- and Furry-mediated activation of NDR1 kinase is critical for precise alignment of mitotic chromosomes. Curr. Biol. 19, 675-681
22. Mardin, B. R., Lange, C., Baxter, J. E., Hardy, T., Scholz, S. R., Fry, A. M. and Schiebel, E. (2010) Components of the Hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction. Nat. Cell Biol. 12, 1166-1176
23. Yabuta, N., Okada, N., Ito, A., Hosomi, T., Nishihara, S., Sasayama, Y., Fujimori, A., Okuzaki, D., Zhao, H., Ikawa, M. et al. (2007) Lats2 is an essential mitotic regulator required for the coordination of cell division. J. Biol. Chem. 282, 19259-19271
24. Jackson, J. R., Patrick, D. R., Dar, M. M. and Huang, P. S. (2007) Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat. Rev. Cancer 7, 107-117
25. Janssen, A. and Medema, R. H. (2011) Mitosis as an anti-cancer target. Oncogene 30, 2799-2809
26. Matson, D. R. and Stukenberg, P. T. (2011) Spindle poisons and cell fate: a tale of two pathways. Mol. Interv. 11, 141-150
27. Terrano, D. T., Upreti, M. and Chambers, T. C. (2010) Cyclin-dependent kinase 1-mediated Bcl-xL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis. Mol. Cell. Biol. 30, 640-656
28. Shen, S. C., Huang, T. S., Jee, S. H. and Kuo, M. L. (1998) Taxol-induced p34cdc2 kinase activation and apoptosis inhibited by 12-O-tetradecanoylphorbol- 13-acetate in human breast MCF-7 carcinoma cells. Cell Growth Differ. 9, 23-29
29. Enserink, J. M. and Kolodner, R. D. (2010) An overview of Cdk1-controlled targets and processes. Cell Div. 5, 11
30. Visintin, R., Craig, K., Hwang, E. S., Prinz, S., Tyers, M. and Amon, A. (1998) The phosphatase Cdc14 triggers mitotic exit by reversal of cdk-dependent phosphorylation. Mol. Cell 2, 709-718
31. Li, L., Ljungman, M. and Dixon, J. E. (2000) The human Cdc14 phosphatases interact with and dephosphorylate the tumor suppressor protein p53. J. Biol. Chem. 275, 2410-2414
32. Mocciaro, A. and Schiebel, E. (2010) Cdc14: a highly conserved family of phosphatases with non-conserved functions? J. Cell Sci. 123, 2867-2876
33. Mailand, N., Lukas, C., Kaiser, B. K., Jackson, P. K., Bartek, J. and Lukas, J. (2002) Deregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation. Nat. Cell Biol. 4, 317-322
34. Wu, J., Cho, H. P., Rhee, D. B., Johnson, D. K., Dunlap, J., Liu, Y. and Wang, Y. (2008) Cdc14B depletion leads to centriole amplification, and its overexpression prevents unscheduled centriole duplication. J. Cell Biol. 181, 475-483
35. Berdougo, E., Nachury, M. V., Jackson, P. K. and Jallepalli, P. V. (2008) The nucleolar phosphatase Cdc14B is dispensable for chromosome segregation and mitotic exit in human cells. Cell Cycle 7, 1184-1190
36. Bassermann, F., Frescas, D., Guardavaccaro, D., Busino, L., Peschiaroli, A. and Pagano, M. (2008) The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint. Cell 134, 256-267
37. Wei, Z., Peddibhotla, S., Lin, H., Fang, X., Li, M., Rosen, J. M. and Zhang, P. (2011) Early-onset aging and defective DNA damage response in Cdc14b-deficient mice. Mol. Cell. Biol. 31, 1470-1477
38. Mocciaro, A., Berdougo, E., Zeng, K., Black, E., Vagnarelli, P., Earnshaw, W., Gillespie, D., Jallepalli, P. and Schiebel, E. (2010) Vertebrate cells genetically deficient for Cdc14A or Cdc14B retain DNA damage checkpoint proficiency but are impaired in DNA repair. J. Cell Biol. 189, 631-639
39. Xiao, L., Chen, Y., Ji, M., Volle, D. J., Lewis, R. E., Tsai, M. Y. and Dong, J. (2011) KIBRA protein phosphorylation is regulated by mitotic kinase Aurora and protein phosphatase 1. J. Biol. Chem. 286, 36304-36315
40. Bothos, J., Tuttle, R. L., Ottey, M., Luca, F. C. and Halazonetis, T. D. (2005) Human LATS1 is a mitotic exit network kinase. Cancer Res. 65, 6568-6575
41. Meijer, L., Borgne, A., Mulner, O., Chong, J. P., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J. G. and Moulinoux, J. P. (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243, 527-536
42. Eggers, J. P., Grandgenett, P. M., Collisson, E. C., Lewallen, M. E., Tremayne, J., Singh, P. K., Swanson, B. J., Andersen, J. M., Caffrey, T. C., High, R. R. et al. (2011) Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-ras. Clin. Cancer Res. 17, 6140-6150
43. Harley, M. E., Allan, L. A., Sanderson, H. S. and Clarke, P. R. (2010) Phosphorylation of mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest. EMBO J. 29, 2407-2420
44. Pagano, M., Pepperkok, R., Lukas, J., Baldin, V., Ansorge, W., Bartek, J. and Draetta, G. (1993) Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J. Cell Biol. 121, 101-111
45. Tsai, L. H., Lees, E., Faha, B., Harlow, E. and Riabowol, K. (1993) The cdk2 kinase is required for the G1 -to-S transition in mammalian cells. Oncogene 8, 1593-1602
46. Trielli, M. O., Andreassen, P. R., Lacroix, F. B. and Margolis, R. L. (1996) Differential taxol-dependent arrest of transformed and nontransformed cells in the G1 phase of the cell cycle, and specific-related mortality of transformed cells. J. Cell Biol. 135, 689-700
47. Tomlinson, V., Gudmundsdottir, K., Luong, P., Leung, K. Y., Knebel, A. and Basu, S. (2010) JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis. Cell Death Dis. 1, e29
48. Du, L., Lyle, C. S. and Chambers, T. C. (2005) Characterization of vinblastine-induced bcl-xL and bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation/dephosphorylation cycle associated with apoptosis induction. Oncogene 24, 107-117
49. cdc2 and its companion cyclin-dependent kinases. Trends Cell Biol. 3, 296-301
50. Dephoure, N., Zhou, C., Villen, J., Beausoleil, S. A., Bakalarski, C. E., Elledge, S. J. and Gygi, S. P. (2008) A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 105, 10762-10767
51. Esteban, V., Vazquez-Novelle, M. D., Calvo, E., Bueno, A. and Sacristan, M. P. (2006) Human Cdc14A reverses CDK1 phosphorylation of Cdc25A on serines 115 and 320. Cell Cycle 5, 2894-2898
52. Bembenek, J. and Yu, H. (2001) Regulation of the anaphase-promoting complex by the dual specificity phosphatase human Cdc14a. J. Biol. Chem. 276, 48237-48242
53. Gray, C. H., Good, V. M., Tonks, N. K. and Barford, D. (2003) The structure of the cell cycle protein Cdc14 reveals a proline-directed protein phosphatase. EMBO J. 22, 3524-3535
54. Hansen, C. A., Bartek, J. and Jensen, S. (2008) A functional link between the human cell cycle-regulatory phosphatase Cdc14A and the atypical mitogen-activated kinase Erk3. Cell Cycle 7, 325-334
55. Lanzetti, L., Margaria, V., Melander, F., Virgili, L., Lee, M. H., Bartek, J. and Jensen, S. (2007) Regulation of the Rab5 GTPase-activating protein RN-tre by the dual specificity phosphatase Cdc14A in human cells. J. Biol. Chem. 282, 15258-15270
56. Tumurbaatar, I., Cizmecioglu, O., Hoffmann, I., Grummt, I. and Voit, R. (2011) Human Cdc14B promotes progression through mitosis by dephosphorylating Cdc25 and regulating Cdk1/cyclin B activity. PLoS ONE 6, e14711
57. 2/M transition through Cdc25A and Cdc25B. J. Biol. Chem. 285, 40544-40553
58. Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A. and Pan, D. (2010) The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev. Cell 19, 27-38
59. Gascoigne, K. E. and Taylor, S. S. (2009) How do anti-mitotic drugs kill cancer cells? J. Cell. Sci. 122, 2579-2585
60. Aylon, Y., Michael, D., Shmueli, A., Yabuta, N., Nojima, H. and Oren, M. (2006) A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev. 20, 2687-2700
61. Lai, D., Ho, K. C., Hao, Y. and Yang, X. (2011) Taxol resistance in breast cancer cells is mediated by the Hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Res. 71, 2728-2738
62. Zhang, X., George, J., Deb, S., Degoutin, J. L., Takano, E. A., Fox, S. B., Bowtell, D. D. and Harvey, K. F. (2011) The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene. Oncogene 30, 2810-2822